by Jim Stallard,Memorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainMantle cell lymphoma (MCL) is a rare and sometimes ruthless form of non-Hodgkin lymphoma. Even when treatme
byUniversity of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainAs novel cancer treatments continually emerge, it is essential to collect data on patients' quality of life along wit
byUniversity of California, Los AngelesCredit: MART PRODUCTION from PexelsUCLA researchers have developed a deep-learning framework that teaches itself quickly to automatically analyze and diagn
Wearable brain imaging device shines a light on how babies respond in real-world situationsbyUniversity College LondonMother Mererid and baby Mabli were volunteers in the study. Credit: Liam Col
byTulane UniversityCredit: Unsplash/CC0 Public DomainNearly half of the nation's National Cancer Institute (NCI)-designated cancer centers required universal masking in key clinical areas du
byTulane UniversityCredit: Unsplash/CC0 Public DomainNearly half of the nation's National Cancer Institute (NCI)-designated cancer centers required universal masking in key clinical areas du
byJohns Hopkins University School of MedicineThe image on the right shows an unhealthy mitochondrion in a T cell exposed to METRNL. Credit: Christopher Jackson, M.D.A protein called Meteorin-lik
byJohns Hopkins University School of MedicineThe image on the right shows an unhealthy mitochondrion in a T cell exposed to METRNL. Credit: Christopher Jackson, M.D.A protein called Meteorin-lik
by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia
by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia
byWileyCredit: Unsplash/CC0 Public DomainSince the first immunotherapy drug to boost the body's immune response against advanced lung cancer was introduced in the United States in 2015, surv
byWileyCredit: Unsplash/CC0 Public DomainSince the first immunotherapy drug to boost the body's immune response against advanced lung cancer was introduced in the United States in 2015, surv
by Julia Bird, Universitätsklinikum HeidelbergProgression-free survival in the intention-to-treat population, category 1 patients. Credit:The Lancet(2024). DOI: 10.1016/S0140-6736(24)00814
by Julia Bird, Universitätsklinikum HeidelbergProgression-free survival in the intention-to-treat population, category 1 patients. Credit:The Lancet(2024). DOI: 10.1016/S0140-6736(24)00814
by Ernie MundellCredit: Anna Tarazevich from PexelsPeople who've had a history of smoking can get alung cancerspotted early—when it's most treatable—through annual CT screening.Unf
by Ernie MundellCredit: Anna Tarazevich from PexelsPeople who've had a history of smoking can get alung cancerspotted early—when it's most treatable—through annual CT screening.Unf
by Julie Grisham,Memorial Sloan Kettering Cancer CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration (FDA) hasgranted accelerated approvalfor the immunotherapy afami
by Julie Grisham,Memorial Sloan Kettering Cancer CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration (FDA) hasgranted accelerated approvalfor the immunotherapy afami
by Impact Journals LLCProposed mode of action of INT-1B3/1B3.INT-1B3/1B3 induces apoptosis and cell death leading to expression of DAMPs, e.g., expression of calreticulin, reduced expression of CD39 a
by Impact Journals LLCProposed mode of action of INT-1B3/1B3.INT-1B3/1B3 induces apoptosis and cell death leading to expression of DAMPs, e.g., expression of calreticulin, reduced expression of CD39 a
by Liz Murphy,Massachusetts General HospitalDistribution of smoking duration (years), smoking intensity (cigarettes per day), and pack-year smoking history among SCCS participants diagnosed with
by Liz Murphy,Massachusetts General HospitalDistribution of smoking duration (years), smoking intensity (cigarettes per day), and pack-year smoking history among SCCS participants diagnosed with
by Jim Stallard,Memorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainMantle cell lymphoma (MCL) is a rare and sometimes ruthless form of non-Hodgkin lymphoma. Even when treatme
by Jim Stallard,Memorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainMantle cell lymphoma (MCL) is a rare and sometimes ruthless form of non-Hodgkin lymphoma. Even when treatme
byKing's College LondonCredit: Unsplash/CC0 Public DomainAutomated insulin delivery systems have, for the first time, been tested for people with type-one diabetes and end-stage kidney disea
Wearable brain imaging device shines a light on how babies respond in real-world situationsbyUniversity College LondonMother Mererid and baby Mabli were volunteers in the study. Credit: Liam Col
by Jim Stallard,Memorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainMantle cell lymphoma (MCL) is a rare and sometimes ruthless form of non-Hodgkin lymphoma. Even when treatme
byNIH/National Human Genome Research InstituteNIH researchers and collaborators have found that being a carrier for sickle cell disease, known as having sickle cell trait, increases the risk of
byUniversity of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainAs novel cancer treatments continually emerge, it is essential to collect data on patients' quality of life along wit
Announcement of the 2024 Nobel Prize in Physiology or Medicine Nobel Prize in Physiology or Medicine...Announcement of the 2024 Nobel Prize in ChemistryThe Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2024 with one half to David Baker, University of Was...AlphaFold: The making of a scientific breakthroughThe inside story of the DeepMind team of scientists and engineers who created AlphaFold, an AI system that is recognised as a solution to "p...